Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cassandra Calabrese

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Cleveland Clinic Journal of Medicine|July 11, 2020
Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1Leonard H Calabrese, Cassandra Calabrese
Frontiers in Medicine|November 8, 2021
Editorial: Infection-Related Rheumatic DiseasesKonstantinos Thomas, Cassandra Calabrese, Dimitrios Vassilopoulos
Best Practice & Research. Clinical Rheumatology|November 11, 2022
Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implicationsCassandra Calabrese, Elizabeth Kirchner, Leonard H Calabrese
Cleveland Clinic Journal of Medicine|August 6, 2020
Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: The role of GM-CSFLeonard H Calabrese, Tiphaine Lenfant, Cassandra Calabrese
Cleveland Clinic Journal of Medicine|August 28, 2020
Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 4: The role of JAK inhibitionLeonard H Calabrese, Tiphaine Lenfant, Cassandra Calabrese
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2026
Target Trial Emulation of Oral Antivirals for B-Cell-Depleted COVID-19 Patients-Reply to Chen et alXiaofeng F Wang, Cassandra Calabrese, Leonard Calabrese
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2016
The 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Should Include New Standards for Hepatitis B Screening: Comment on the Article by Singh et alLeonard H Calabrese, Cassandra Calabrese, Elizabeth Kirchner
Cleveland Clinic Journal of Medicine|November 21, 2020
Interferon therapy for COVID-19 and emerging infections: Prospects and concernsLeonard H Calabrese, Tiphaine Lenfant, Cassandra Calabrese
Arthritis Care & Research|February 12, 2016
The 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Should Include New Standards for Hepatitis B Screening: Comment on the Article by Singh et alLeonard H Calabrese, Cassandra Calabrese, Elizabeth Kirchner
Current Dermatology Reports|August 29, 2022
Outpatient Management of COVID-19: A Primer for the DermatologistSonia Wang, Joel M Gelfand, Cassandra Calabrese
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Cleveland Clinic Journal of Medicine|July 11, 2020
Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1Leonard H Calabrese, Cassandra Calabrese
Frontiers in Medicine|November 8, 2021
Editorial: Infection-Related Rheumatic DiseasesKonstantinos Thomas, Cassandra Calabrese, Dimitrios Vassilopoulos
Best Practice & Research. Clinical Rheumatology|November 11, 2022
Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implicationsCassandra Calabrese, Elizabeth Kirchner, Leonard H Calabrese
Cleveland Clinic Journal of Medicine|August 6, 2020
Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: The role of GM-CSFLeonard H Calabrese, Tiphaine Lenfant, Cassandra Calabrese
Cleveland Clinic Journal of Medicine|August 28, 2020
Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 4: The role of JAK inhibitionLeonard H Calabrese, Tiphaine Lenfant, Cassandra Calabrese
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2026
Target Trial Emulation of Oral Antivirals for B-Cell-Depleted COVID-19 Patients-Reply to Chen et alXiaofeng F Wang, Cassandra Calabrese, Leonard Calabrese
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2016
The 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Should Include New Standards for Hepatitis B Screening: Comment on the Article by Singh et alLeonard H Calabrese, Cassandra Calabrese, Elizabeth Kirchner
Cleveland Clinic Journal of Medicine|November 21, 2020
Interferon therapy for COVID-19 and emerging infections: Prospects and concernsLeonard H Calabrese, Tiphaine Lenfant, Cassandra Calabrese
Arthritis Care & Research|February 12, 2016
The 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Should Include New Standards for Hepatitis B Screening: Comment on the Article by Singh et alLeonard H Calabrese, Cassandra Calabrese, Elizabeth Kirchner
Current Dermatology Reports|August 29, 2022
Outpatient Management of COVID-19: A Primer for the DermatologistSonia Wang, Joel M Gelfand, Cassandra Calabrese
Pageof 7